Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020;7(3):361-364.
doi: 10.3233/JND-200520.

COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome

Affiliations
Case Reports

COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome

Swathi Beladakere Ramaswamy et al. J Neuromuscul Dis. 2020.

Abstract

This is a brief report of a patient who has refractory Myasthenia Gravis, on multiple long-term immunosuppressive therapies and contracted COVID-19 during this 2020 pandemic. She was quarantined for total of 14 days and recovered successfully without any complications (no myasthenia exacerbation or crisis, no COVID-19 related complications), with no changes to her immunosuppressive therapy. Treatment of MG patients with COVID-19 needs to be tailored to individual patient.

Keywords: COVID-19; Plasmapheresis; Refractory Myasthenia Gravis; immunosuppression; outcome.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to report.

References

    1. Ciafaloni E. Myasthenia Gravis and Congenital Myasthenic syndromes. Continuum (Minneap Minn). 2019;25(6):1767–84. - PubMed
    1. Gilhus NE, Verschuuren JJ. Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol. 2015;14:1023–36. - PubMed
    1. Gilhus NE. Myasthenia gravis. N Engl J Med. 2016;375:2570–2581. - PubMed
    1. Gilhus NE, Nacu A, Andersen JB, Owe JF. Myasthenia gravis and risks for comorbidity. Eur J Neurol. 2015;22:17–23. - PubMed
    1. Wendell LC, Levine JM. Myasthenic crisis. Neurohospitalist. 2011;1(1):16–22. - PMC - PubMed

Publication types

Substances